WHO ICTRP trial
EpSSG RMS 2005 a protocol for non metastatic rhabdomyosarcoma
EUCTR2005-000217-35-NO · EU Clinical Trials Register
Key facts
| Trial ID | EUCTR2005-000217-35-NO |
|---|---|
| Public title | EpSSG RMS 2005 a protocol for non metastatic rhabdomyosarcoma |
| Scientific title | EpSSG RMS 2005 a protocol for non metastatic rhabdomyosarcoma |
| Primary sponsor | Rikshospitalet-Radiumhospitalet HF |
| Registry | EU Clinical Trials Register |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Spain;Belgium;Ireland;Netherlands;Norway;Italy |
| Conditions | Rhabdomyosarkom (RMS) er en kreftform utgående fra muskelvev. RMS kan oppstå hvor som helst i kroppen og rammer folk i alle aldre. Behandlingen av RMS består av cellegift, operasjon og/eller strålebehandling. Behandlingsresultatene er ikke… |
| Interventions | Trade Name: Doxorubicin Pharmaceutical Form: Intravenous infusion Trade Name: Sendoxan Pharmaceutical Form: Tablet Trade Name: Navelbine Pharmaceutical Form: Intravenous infusion Trade Name: Holoxan Pharmaceutical Form: Intravenous infusion… |
| Registration date | Jan 31, 2006 |
| Target size | 1200 |
| Secondary IDs | EpSSG RMS 2005 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: